ATE81284T1 - Lyophilisierter schaum. - Google Patents

Lyophilisierter schaum.

Info

Publication number
ATE81284T1
ATE81284T1 AT87900555T AT87900555T ATE81284T1 AT E81284 T1 ATE81284 T1 AT E81284T1 AT 87900555 T AT87900555 T AT 87900555T AT 87900555 T AT87900555 T AT 87900555T AT E81284 T1 ATE81284 T1 AT E81284T1
Authority
AT
Austria
Prior art keywords
lyophilized foam
lyophilized
foam
insecticide
fertilizer
Prior art date
Application number
AT87900555T
Other languages
English (en)
Inventor
J Desmond Davies
Original Assignee
Scherer Corp R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherer Corp R P filed Critical Scherer Corp R P
Application granted granted Critical
Publication of ATE81284T1 publication Critical patent/ATE81284T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/16—Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasonic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasonic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223—Microbubbles, hollow microspheres, free gas bubbles, gas microspheres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • C—CHEMISTRY; METALLURGY
    • C05—FERTILISERS; MANUFACTURE THEREOF
    • C05G—MIXTURES OF FERTILISERS COVERED INDIVIDUALLY BY DIFFERENT SUBCLASSES OF CLASS C05; MIXTURES OF ONE OR MORE FERTILISERS WITH MATERIALS NOT HAVING A SPECIFIC FERTILISING ACTIVITY, e.g. PESTICIDES, SOIL-CONDITIONERS, WETTING AGENTS; FERTILISERS CHARACTERISED BY THEIR FORM
    • C05G5/00—Fertilisers characterised by their form
    • C05G5/10—Solid or semi-solid fertilisers, e.g. powders
    • C05G5/18—Semi-solid fertilisers, e.g. foams or gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Zoology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Acoustics & Sound (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Environmental Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Fertilizers (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT87900555T 1986-12-19 1986-12-19 Lyophilisierter schaum. ATE81284T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US1986/002724 WO1988004551A1 (en) 1986-12-19 1986-12-19 Freeze-dried foam
EP87900555A EP0295242B1 (de) 1986-12-19 1986-12-19 Lyophilisierter schaum

Publications (1)

Publication Number Publication Date
ATE81284T1 true ATE81284T1 (de) 1992-10-15

Family

ID=22195760

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87900555T ATE81284T1 (de) 1986-12-19 1986-12-19 Lyophilisierter schaum.

Country Status (7)

Country Link
US (1) US4642903A (de)
EP (1) EP0295242B1 (de)
JP (1) JP2527776B2 (de)
AT (1) ATE81284T1 (de)
AU (1) AU614926B2 (de)
DE (1) DE3686953T2 (de)
WO (1) WO1988004551A1 (de)

Families Citing this family (111)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5215756A (en) * 1989-12-22 1993-06-01 Gole Dilip J Preparation of pharmaceutical and other matrix systems by solid-state dissolution
US5188825A (en) * 1989-12-28 1993-02-23 Iles Martin C Freeze-dried dosage forms and methods for preparing the same
GR910100193A (el) * 1991-05-03 1993-03-31 Mediventures Inc Παρασκευη φαρμακευτικων και αλλων περιβληματων με διαλυση σε στερεα κατασταση.
DE59303759C5 (de) * 1992-01-17 2009-04-09 Alfatec-Pharma Gmbh Wirkstoff-enthaltende festkörper mit einem gerüst aus hydrophilen makromolekülen und verfahren zu ihrer herstellung
US5840777A (en) * 1992-06-19 1998-11-24 Albany International Corp. Method of producing polysaccharide foams
US5458884A (en) * 1992-09-10 1995-10-17 Britton; Peter Bioerodible device for administering active ingredients
NO933239D0 (no) * 1992-09-10 1993-09-10 Mcneil Ppc Inc Bioeroderbar innretning for administering av aktive ingredienser
GB9401892D0 (en) * 1994-02-01 1994-03-30 Boots Co Plc Therapeutic agents
NO953115L (no) 1995-06-07 1996-12-09 Albany Int Research Fremgangsmåte for fremstilling av polysakkaridskum
US5958589A (en) * 1995-07-07 1999-09-28 The United States Of America As Represented By The Secretary Of Agriculture Starch-based microcellular foams
CA2246778A1 (en) * 1996-02-19 1997-08-21 Per Helge Gulliksen Thermally stabilized contrast agent
US6165442A (en) * 1996-02-19 2000-12-26 Nycomed Imaging As Thermally stabilized ultrasound contrast agent
US6509146B1 (en) 1996-05-29 2003-01-21 Universal Preservation Technologies, Inc. Scalable long-term shelf preservation of sensitive biological solutions and suspensions
US5766520A (en) * 1996-07-15 1998-06-16 Universal Preservation Technologies, Inc. Preservation by foam formation
US5837286A (en) * 1997-01-15 1998-11-17 Pandya; Harish B. Taste masking for unplatable formulations
WO1998036738A1 (en) 1997-02-20 1998-08-27 Therics, Inc. Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same
US20020106412A1 (en) * 2000-07-10 2002-08-08 Therics, Inc Method and materials for controlling migration of binder liquid in a powder
US5976577A (en) * 1997-07-11 1999-11-02 Rp Scherer Corporation Process for preparing fast dispersing solid oral dosage form
ATE323467T1 (de) * 1997-07-25 2006-05-15 Alpex Pharma Sa Verfahren zur herstellung eines granulates, geeignet zur herstellung schnell-freisetzender, im mund löslicher tabletten
US5968362A (en) 1997-08-04 1999-10-19 Controlled Enviromental Systems Corporation Method for the separation of acid from sugars
GB9717542D0 (en) 1997-08-19 1997-10-22 Nycomed Imaging As Process
US20040013613A1 (en) * 2001-05-18 2004-01-22 Jain Rajeev A Rapidly disintegrating solid oral dosage form
US8236352B2 (en) * 1998-10-01 2012-08-07 Alkermes Pharma Ireland Limited Glipizide compositions
US6090401A (en) * 1999-03-31 2000-07-18 Mcneil-Ppc, Inc. Stable foam composition
US6319510B1 (en) 1999-04-20 2001-11-20 Alayne Yates Gum pad for delivery of medication to mucosal tissues
US20040115134A1 (en) * 1999-06-22 2004-06-17 Elan Pharma International Ltd. Novel nifedipine compositions
US6284270B1 (en) 1999-08-04 2001-09-04 Drugtech Corporation Means for creating a mass having structural integrity
US6316029B1 (en) 2000-05-18 2001-11-13 Flak Pharma International, Ltd. Rapidly disintegrating solid oral dosage form
US6982251B2 (en) * 2000-12-20 2006-01-03 Schering Corporation Substituted 2-azetidinones useful as hypocholesterolemic agents
US6814978B2 (en) 2000-12-29 2004-11-09 Mcneil-Ppc, Inc. Process for preparing a soft tablet
US7071181B2 (en) * 2001-01-26 2006-07-04 Schering Corporation Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
RS20100015A (sr) * 2001-01-26 2010-12-31 Schering Corporation Kombinacija aktivatora receptora aktiviranog peroksizom- proliferatorom (ppar) fenofibrata sa inhibitorom apsorpcije sterola ezetimibom za vaskularne indikacije
US20060287254A1 (en) * 2001-01-26 2006-12-21 Schering Corporation Use of substituted azetidinone compounds for the treatment of sitosterolemia
IL156488A0 (en) * 2001-01-26 2004-01-04 Schering Corp Combinations of sterol absorption inhibitor(s) with blood modifier(s) for treating vascular conditions
EP1353695A2 (de) * 2001-01-26 2003-10-22 Schering Corporation Kombinationen von einem hemmer der sterol-absorption und nicotinsäure zur behandlung von kardiovaskulären indikationen
PT1355644E (pt) * 2001-01-26 2006-11-30 Schering Corp Utilização de compostos azetidinona substituídos para o tratamento de sitosterolemia
IL156585A0 (en) * 2001-01-26 2004-01-04 Schering Corp Combinations of sterol absorption inhibitor(s) with cardiovascular agent(s) for the treatment of vascular conditions
ATE369851T1 (de) * 2001-01-26 2007-09-15 Schering Corp Kombinationen von gallensäuresequestriermitteln und hemmern der sterolabsorption zur behandlung von kardiovaskulären indikationen
DE60216275T2 (de) * 2001-05-25 2007-06-21 Schering Corp. Verwendung von mit azetidinon substituierten derivaten bei der behandlung der alzheimer-krankheit
PL368612A1 (en) * 2001-08-14 2005-04-04 Biotie Therapies Corporation Method of treating alcoholism or alcohol abuse
CN101785772A (zh) * 2001-09-21 2010-07-28 先灵公司 使用甾醇吸收抑制剂治疗或预防脉管炎的方法
US20030119808A1 (en) * 2001-09-21 2003-06-26 Schering Corporation Methods of treating or preventing cardiovascular conditions while preventing or minimizing muscular degeneration side effects
US7053080B2 (en) * 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
EP1429756B1 (de) * 2001-09-21 2006-11-22 Schering Corporation Behandlung von xanthom mittels azetidinon-derivate als hemmer der sterol absorption
US7056906B2 (en) * 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
DE60222160T2 (de) * 2001-10-12 2008-06-12 Elan Pharma International Ltd., Athlone Zusammensetzungen mit einer kombination aus eigenschaften sofortiger freisetzung und kontrollierter freisetzung
US20030180242A1 (en) * 2001-11-01 2003-09-25 The Procter & Gamble Company Personal care compositions containing a water-disintegratable polymeric foam
US20030186826A1 (en) * 2001-11-01 2003-10-02 The Procter & Gamble Company Method of using personal care compositions containing a high density, water disintegratable, polymeric foam
EP1941878A1 (de) 2002-01-10 2008-07-09 Biovail Laboratories International Srl Sedative Formulierungen ohne Benzodiazepin
EP1487419A2 (de) * 2002-03-20 2004-12-22 Elan Pharma International Limited Schnell auflösende dosierformen mit verringerter sprödigkeit
WO2003087327A2 (en) * 2002-04-11 2003-10-23 Medimmune Vaccines, Inc. Preservation of bioactive materials by freeze dried foam
US20030215498A1 (en) * 2002-05-17 2003-11-20 Harland Ronald S. Rapidly disintegrating comressed tablets comprising biologically active compounds
JP2006508188A (ja) * 2002-11-06 2006-03-09 シェーリング　コーポレイション 脱髄の処置のためのコレステロール吸収インヒビター
JP4776233B2 (ja) * 2002-11-12 2011-09-21 エラン ファーマ インターナショナル，リミティド 摩損しにくくかつプルランを含む速崩壊性固形製剤
CN1756756A (zh) * 2003-03-07 2006-04-05 先灵公司 取代的2－吖丁啶酮化合物、其制剂及其治疗高胆甾醇血症的用途
CN1756755A (zh) * 2003-03-07 2006-04-05 先灵公司 取代的2－吖丁啶酮化合物、其制剂及其治疗高胆甾醇血症的用途
DE602004016123D1 (de) 2003-03-07 2008-10-09 Schering Corp Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia
US7459442B2 (en) * 2003-03-07 2008-12-02 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
US20050036977A1 (en) * 2003-08-11 2005-02-17 Dilip Gole Taste-masked resinate and preparation thereof
JP2007510659A (ja) * 2003-11-05 2007-04-26 シェーリング　コーポレイション 脂質調節剤および置換アゼチジノンの組み合わせならびに血管状態の処置
US7670624B2 (en) * 2004-01-29 2010-03-02 Astella Pharma Inc. Gastrointestinal-specific multiple drug release system
US20050186271A1 (en) * 2004-02-24 2005-08-25 Sheskey Paul J. Process for dispersing a fluid in a mass of solid particles
DK1804804T3 (da) 2004-09-21 2012-02-20 Hypnion Inc 3-[4-(dibenzo[b,f][1,4]oxazepin-11-yl)-piperazin-1-yl]-2,2-dimethylpropansyre til anvendelse ved behandlingen af søvnforstyrrelser
EP1909910A1 (de) 2005-08-04 2008-04-16 Sirtris Pharmaceuticals, Inc. Benzimidazol-derivative als sirtuin-modulatoren
JP4945157B2 (ja) * 2006-03-27 2012-06-06 株式会社東芝 復元力に優れた再生可能な発泡成形体およびその製造方法ならびにその再生方法
JP2007262282A (ja) * 2006-03-29 2007-10-11 Toshiba Corp 吸音材料およびその製造方法、ならびに吸音材料の再生方法
US20070243248A1 (en) * 2006-04-14 2007-10-18 Cherukuri S Rao Rapidly disintegrating solid oral dosage form of liquid dispersions
WO2007130373A2 (en) * 2006-05-01 2007-11-15 Capricorn Pharma, Inc. Novel triptan formulations and methods for making them
EP1870649A1 (de) 2006-06-20 2007-12-26 Octapharma AG Gefriertocknung zum Erzielen einer bestimmte Restfeuchte durch beschränkte Desorptionsenergiepegeln.
ES2500165T3 (es) 2006-06-29 2014-09-30 Kinex Pharmaceuticals, Llc Composiciones de biarilo y métodos para modular una cascada de quinasas
US20090060983A1 (en) * 2007-08-30 2009-03-05 Bunick Frank J Method And Composition For Making An Orally Disintegrating Dosage Form
EP3777832A1 (de) 2007-10-20 2021-02-17 Athenex, Inc. Pharmazeutische zubereitung zur veränderung der kinase kasakade und deren verwendung
KR101560176B1 (ko) * 2007-10-31 2015-10-14 맥네일-피피씨, 인코포레이티드 구강내 붕해성 투여 형태
CN101482359B (zh) * 2009-02-11 2010-04-14 中国农业科学院植物保护研究所 一种孢子粉干燥方法
EP2413883A1 (de) 2009-04-01 2012-02-08 Colgate-Palmolive Company Zahnputzzusammensetzungen und verfahren zur behandlung und prophylaxe von beschädigungen der zahnoberfläche
US8858210B2 (en) 2009-09-24 2014-10-14 Mcneil-Ppc, Inc. Manufacture of variable density dosage forms utilizing radiofrequency energy
US8343533B2 (en) 2009-09-24 2013-01-01 Mcneil-Ppc, Inc. Manufacture of lozenge product with radiofrequency
US8313768B2 (en) 2009-09-24 2012-11-20 Mcneil-Ppc, Inc. Manufacture of tablet having immediate release region and sustained release region
US20110070286A1 (en) * 2009-09-24 2011-03-24 Andreas Hugerth Process for the manufacture of nicotine-comprising chewing gum and nicotine-comprising chewing gum manufactured according to said process
TR201002084A1 (tr) 2010-03-19 2011-10-21 Sanovel İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ Oral yolla dağılan donepezil tablet formülasyonları ve hazırlama yöntemi
EP2377522B1 (de) 2010-04-15 2013-01-16 Sanovel Ilaç Sanayi Ve Ticaret Anonim Sirketi Formulierungen von im Mund zerfallenden Mirtazapintabletten und Herstellungsverfahren dafür.
EP2611781A1 (de) 2010-09-01 2013-07-10 Arena Pharmaceuticals, Inc. Schnelllösliche darreichungsformen von 5-ht2c-agonisten
WO2012056319A1 (en) 2010-10-27 2012-05-03 Dynamix Pharmaceuticals Ltd. Sulfonamides for the modulation of pkm2
EP2655334B1 (de) 2010-12-22 2018-10-03 Eutropics Pharmaceuticals, Inc. Zusammensetzungen und verfahren zur behandlung von erkrankungen
US8900557B2 (en) 2010-12-30 2014-12-02 Jr Chem, Llc Dental cleaning composition
WO2012125297A1 (en) 2011-03-01 2012-09-20 The Procter & Gamble Company Porous disintegratable solid substrate for personal health care applications
WO2012122370A2 (en) 2011-03-08 2012-09-13 Eutropics Pharmaceuticals, Inc. Compositions and methods useful for treating diseases
WO2012160447A1 (en) 2011-05-25 2012-11-29 Dynamix Pharmaceuticals Ltd. 3, 5 -diphenyl- substituted pyrazolines for the treatment of cancer, proliferative, inflammatory or autoimmune diseases
PT2718290T (pt) 2011-06-07 2016-07-14 Clevexel Pharma Composições e métodos para modular uma quinase
EP2609911A1 (de) 2011-12-29 2013-07-03 Sanovel Ilac Sanayi ve Ticaret A.S. Neuartiges Verfahren zur Herstellung von oral zerfallenden Flurbiprofen-Formulierungen
CN102755253A (zh) * 2012-01-17 2012-10-31 海南卫康制药(潜山)有限公司 制造在相连的盛药皿包装内冷冻干燥片剂的方法
US9445971B2 (en) 2012-05-01 2016-09-20 Johnson & Johnson Consumer Inc. Method of manufacturing solid dosage form
US9233491B2 (en) 2012-05-01 2016-01-12 Johnson & Johnson Consumer Inc. Machine for production of solid dosage forms
US9511028B2 (en) 2012-05-01 2016-12-06 Johnson & Johnson Consumer Inc. Orally disintegrating tablet
IN2014DN11205A (de) 2012-06-20 2015-10-02 Eutropics Pharmaceuticals Inc
JP6499076B2 (ja) 2012-08-30 2019-04-10 アセネックス インコーポレイテッド タンパク質チロシンキナーゼ調節因子としてのｎ−（３−フルオロベンジル）−２−（５−（４−モルホリノフェニル）ピリジン−２−イル）アセトアミド
US9339489B2 (en) 2013-03-15 2016-05-17 Aprecia Pharmaceuticals Company Rapid disperse dosage form containing levetiracetam
AU2014228990B2 (en) 2013-03-15 2017-02-02 Aprecia Pharmaceuticals LLC Rapid disperse dosage form containing levetiracetam
CA2906107C (en) 2013-03-15 2021-08-24 Aprecia Pharmaceuticals Company Rapidly dispersible dosage form of oxcarbazepine
WO2014144661A1 (en) 2013-03-15 2014-09-18 Aprecia Pharmaceuticals Compny Rapidly dispersible dosage form of topiramate
US9789066B2 (en) 2014-01-10 2017-10-17 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles
WO2017168174A1 (en) 2016-04-02 2017-10-05 N4 Pharma Uk Limited New pharmaceutical forms of sildenafil
WO2018002673A1 (en) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Novel formulations of angiotensin ii receptor antagonists
EP3497099B1 (de) 2016-08-12 2022-03-02 Athenex, Inc. Biarylzusammensetzungen und verfahren zur modulierung einer kinasekaskade
JP7219712B2 (ja) 2016-10-13 2023-02-08 キャタレント・ユーケー・スウィンドン・ザイディス・リミテッド 膣送達のための凍結乾燥医薬組成物
WO2018115888A1 (en) 2016-12-21 2018-06-28 N4 Pharma Uk Limited Novel formulations of aprepitant
US10493026B2 (en) 2017-03-20 2019-12-03 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles
CZ307916B6 (cs) 2017-05-08 2019-08-21 mcePharma s. r. o. Orodispergovatelná tableta s biodostupným kurkuminem a její použití
WO2020104837A1 (en) 2018-11-21 2020-05-28 Rosemont Pharmaceuticals Limited Oral topiramate suspension formulations with extended shelf stability and enhanced bioavailability
US10758329B1 (en) 2019-08-20 2020-09-01 Raymond L. Wright, III Hydrating mouth guard
AU2021296908A1 (en) 2020-06-26 2023-02-16 Aprecia Pharmaceuticals LLC Rapidly-orodispersible tablets having an interior cavity

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3064722A (en) * 1960-01-11 1962-11-20 Jr Arthur I Morgan Production of carbohydrates in readily dispersible form
CH463935A (fr) * 1966-07-08 1968-10-15 Nestle Sa Procédé de fabrication d'un produit complexe à structure poreuse et produit obtenu par ce procédé
US3514518A (en) * 1967-12-19 1970-05-26 Pierre Charier Vadrot Process for preparation of gelatinous material from animal collagen
US3804960A (en) * 1968-09-26 1974-04-16 Gen Foods Corp Preparation of extract for freeze drying
US3482990A (en) * 1969-02-10 1969-12-09 Gen Foods Corp Freeze-drying of foamed aromatic material
US3653929A (en) * 1969-10-21 1972-04-04 Gen Foods Corp Process of freeze drying coffee
BE787573A (fr) * 1971-10-22 1973-02-14 Hag Ag Procede de fabrication de poudres ayant la couleur de la substance de depart, a partir d'extraits aqueux de produits vegetaux par lyophilisation
US4190427A (en) * 1977-05-04 1980-02-26 General Foods Corporation Plant care composition
CA1097233A (en) * 1977-07-20 1981-03-10 George K. E. Gregory Packages
FR2403078A1 (fr) * 1977-09-19 1979-04-13 Lafon Labor Nouveau procede de preparation de formes pharmaceutiques, cosmetiques ou de diagnostic
US4180917A (en) * 1978-09-05 1980-01-01 Rohm And Haas Company Process for freeze-drying enzymes
DE3004162A1 (de) * 1980-02-05 1981-08-13 Hag Ag, 2800 Bremen Verfahren zum trocknen von fluessigen oder pastoesen produkten, welche fluechtige oder temperaturempfindliche aromastoffe enthalten
US4292972A (en) * 1980-07-09 1981-10-06 E. R. Squibb & Sons, Inc. Lyophilized hydrocolloio foam

Also Published As

Publication number Publication date
AU6739487A (en) 1988-07-15
EP0295242A1 (de) 1988-12-21
US4642903A (en) 1987-02-17
JPH01501704A (ja) 1989-06-15
EP0295242B1 (de) 1992-10-07
JP2527776B2 (ja) 1996-08-28
DE3686953D1 (de) 1992-11-12
WO1988004551A1 (en) 1988-06-30
DE3686953T2 (de) 1993-03-18
AU614926B2 (en) 1991-09-19

Similar Documents

Publication Publication Date Title
AU6739487A (en) Freeze-dried foam
BG44205A3 (en) Method for preparing of antibiotic s541
CA2009508A1 (en) Pf 1022 substance, method of producing same and anthelmintic composition containing same
NO884154D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive preparater.
NO904754L (no) Kapsel for innkapsling av biologisk aktive materialer, fremgangsmaate for fremstilling av denne, samt anvendelse derav.
NO165843C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-6 -substituerte adenosiner.
NO880182D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1, 2-dihydro-3h-indazol-3h-indazol-3-on-derivater.
EP0283505A4 (de) Impfstoff und verfahren zur herstellung.
ES8800601A1 (es) Un procedimiento para preparar una formulacion farmaceutica liofilizada de activador de plasminogeno de tejidro (t-pa)
ES522637A0 (es) Procedimiento para la preparacion de nuevas sustancias ws 6049.
AU5797390A (en) Antibiotic agent
DE3869670D1 (de) Latex fuer die immobilisierung von physiologisch aktiven verbindungen und reaktiver latex, der diesen latex verwendet.
ES2067520T3 (es) Antibioticos y procedimiento para su produccion.
DE59001005D1 (de) Hilfsmittelfreie riboflavingranulate.
NO872919D0 (no) Fremstilling av pertussis-toksin ved dyrkning av bodella pertussis.
DE3764235D1 (de) Ifosfamid-lyophilisat und verfahren zu dessen herstellung.
NO873680L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive sulfonamido-etyl-forbindelser.
NO881768L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner.
ATE55985T1 (de) 4-benzyloxy-3-pyrrolin-2-on-1-yl-acetamid, dessen herstellung und verwendung.
NO166280C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n,n'-disubstituerte ureaer.
AU5848690A (en) Preparation for topical treatment of infections caused by virus, bacteria and fungi
IE780205L (en) Insulin-secretion promoting protein.
NO892087D0 (no) Fremgangsmaate for fremstilling av nye avermectiner med enspaltet furanring og en 8alfa -hydroxygruppe.
HUP9600847A2 (hu) Primicinek ciklodextrinszármazékokkal alkotott új nemsztöchiometrikus vegyületei, ilyen vegyületeket tartalmazó gyógyszerkészítmények és eljárás a vegyületek előállítására
EP0659759A4 (de)

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time